NIH-GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue Reading NIH-GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

BMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue Reading BMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

BMGF – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue Reading BMGF – CureVac, Global Access Commitments Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue Reading CEPI – CureVac, Framework Partnering Agreement

Pfizer – Peru, COVID-19 Vaccine Binding Term Sheet

• Post author:GHIAA Editor
• Post published:June 28, 2021
• Post category:

Continue Reading Pfizer – Peru, COVID-19 Vaccine Binding Term Sheet

Pfizer/BioNTech-Dominican Republic Binding Term Sheet

• Post author:GHIAA Editor
• Post published:June 3, 2021
• Post category:

Continue Reading Pfizer/BioNTech-Dominican Republic Binding Term Sheet

CEPI – Novavax, COVID-19 Vaccine Funding Agreement

• Post author:GHIAA Editor
• Post published:May 14, 2021
• Post category:

Continue Reading CEPI – Novavax, COVID-19 Vaccine Funding Agreement

Israel – Pfizer, Epidemiological Evidence Collaboration Agreement

• Post author:GHIAA Editor
• Post published:May 6, 2021
• Post category:

Continue Reading Israel – Pfizer, Epidemiological Evidence Collaboration Agreement

Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

• Post author:GHIAA Admin
• Post published:December 14, 2020
• Post category:

Continue Reading Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement